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Background: Migrants within the European Union and 
European Economic Area (EU/EEA) may be underim-
munised and lack documentation on previous vaccina-
tions. We investigated approaches to vaccination in 
recently arrived adult and child migrants, and guideline 
availability and implementation.  Methods: Between 
March and May 2017, a national vaccination expert 
from every EU/EEA country and Switzerland com-
pleted an electronic questionnaire. We used descrip-
tive analyses to calculate percentages, and framework 
analysis to synthesise free-text responses.  Results: 
We approached 32 countries (response rate 100%). 
Although 28 experts reported vaccination guidance at 
national level, specific guidelines for recently arrived 
migrants were only available in six countries and not 
consistently implemented. Twenty-three countries 
administered vaccinations during on-arrival health 
checks. Most experts recommended multiple vaccina-
tion opportunities be made available: at point of entry 
(n = 13) or at holding level (reception centres, migrant 
camps, detention centres) (n = 21). In 30 countries, 
child migrants without evidence of previous vacci-
nation were re-vaccinated according to the national 
schedule. Diphtheria-pertussis-tetanus and polio vac-
cinations were given to migrant children in all coun-
tries, measles-mumps-rubella (MMR) in 31 countries, 
hepatitis B vaccination in 25. Low levels of catch-up 
vaccination were reported in adult migrants, with only 
13 countries offering MMR and 10 countries charg-
ing fees.  Conclusion: Existing guidance is often not 
migrant-specific and may not be applied in practice; 
clarification is needed on which vaccines should be 
given. Strategies are needed specifically for catch-
up vaccination in adult migrants. Vaccinations should 
be offered in multiple settings, free of charge, with 
sufficient guidance and training provided to front-line 
healthcare professionals.
Introduction
Ensuring high levels of vaccination coverage is a key 
priority for the European Union (EU) [1-4]; yet very 
high levels of both external and internal migration in 
the region in recent years have posed considerable 
challenges to achieving this. Migrants, including refu-
gees and asylum seekers, may be underimmunised if 
they have come from countries whose healthcare sys-
tem has been disrupted due to war or other circum-
stances, which makes them vulnerable to acquiring 
infection if exposed [5-7]. Syrian and Afghan migrants, 
dominant migrant groups to the EU in recent years [8], 
have relatively low vaccine coverage rates. For exam-
ple, immunisation coverage in Syria is around 40% 
for diphtheria, tetanus and pertussis (DTP) and 50% 
for polio [9,10]. Greece recently reported vaccination 
status as ‘unknown’ in 79.3% of Syrian children dur-
ing an outbreak of hepatitis A in migrant camps [11]. 
Outbreaks of vaccine-preventable diseases such as 
measles have been seen among migrants in Europe, 
which may reflect sub-optimal vaccination coverage 
in migrant populations [12,13]. Many migrants lack any 
documentation of their vaccination history. The role of 
serology in assessing vaccination status is not clear 
and clinically relevant information about the useful-
ness of serology for migrants arriving in host countries 
is not available. Serological testing is, for example, 
not recommended for polio in migrants arriving to the 
United States, [14], but it is used for other infections in 
other groups, for example travellers going abroad and 
presenting for pre-travel advice. Most countries do not 
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routinely check serology before vaccination of arriving 
migrants because of cost and logistical issues.
On arrival to the receiving country, migrants may face 
multiple barriers to accessing healthcare, including 
catch-up vaccinations [15,16]. Migrants are known to 
face barriers to accessing primary-care physicians, 
where most vaccination and screening for infection 
routinely occurs [17], and may be charged for any 
healthcare they receive, which may mean that seeking 
preventative healthcare such as vaccination becomes 
less of a priority [18]. Undocumented migrants in par-
ticular may fear approaching health services because 
of links with immigration authorities.
The European Vaccine Action Plan (EVAP) has set out 
a series of goals and objectives for immunisation 
and control of vaccine-preventable diseases (VPD) in 
the European Region member states for 2015–20 [4], 
emphasising that special attention should be paid to 
migrants and marginalised communities, ensuring 
their eligibility and access to appropriate immunisa-
tion services and information. However, strategies 
and approaches to engaging this group are lacking, as 
are high-quality studies assessing vaccination imple-
mentation in migrant populations [19]. The Promote 
Vaccination among Migrant Populations in Europe 
(PROVOMAX) project, which ended in 2013, sought to 
promote vaccination among migrants and develop rec-
ommendations for policymakers [20]. The European 
Centre for Disease Prevention and Control (ECDC) 
Vaccine Scheduler database (https://vaccine-schedule.
ecdc.europa.eu) highlights immunisation schedules in 
all EU countries and allows comparison of vaccination 
policies between countries [21]. This provides a sense 
of what every country is doing, but the database does 
not have data on vaccine schedules for migrants.
There remain numerous questions around optimal 
vaccination strategies in migrants, including which 
vaccinations should be prioritised in adult and child 
migrants and how to promote vaccination uptake in 
this group and implement effective and cost-effective 
programmes. We therefore approached national vacci-
nation experts from every EU and European Economic 
Area (EEA) country and Switzerland to complete an 
electronic questionnaire survey exploring current and 
preferred approaches to vaccination in recently arrived 
migrants, guideline availability and implementation, 
different approaches in adults and children, the extent 
to which charges or fees were applied. The survey also 
contained open-ended questions to allow experts to 
document promotional activities in migrants and per-
spectives from across the region.
Methods
Questionnaire development
We developed an electronic 12-point question-
naire survey containing structured and open-ended 
Figure 1
Vaccinations administered to adult and child migrants: approaches identified across Europe, 2017 (n = 32 countries)
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questions around country-specific vaccination poli-
cies for recently arrived migrants in the EU/EEA and 
Switzerland. Switzerland was included because the 
country has been hosting large numbers of refugees 
since 2015. This approach of engaging national experts 
has been successfully used previously in this field [22]. 
Questionnaire development was informed by a narra-
tive synthesis of existing literature on migrant vaccina-
tion in Europe. For the purposes of this research, we 
defined recently arrived migrants as foreign-born and 
living in the host country for less than 10 years. At the 
top of the questionnaire we alerted experts to the fact 
that recently arrived migrants included a variety of 
migrants, specifying definitions for refugees (granted 
asylum in the host country), asylum seekers (awaiting 
a decision on their asylum application) and undocu-
mented migrants (without the necessary authorisation 
or documents required under the host country’s immi-
gration regulations). We defined children as individu-
als aged between 0 and 18 years.
The questionnaire (Supplement 1) included specific 
questions on the availability of national or regional 
guidelines for vaccinations in recently arrived 
migrants, and the extent to which they are applied in 
practice. In addition, questions were asked about what 
vaccinations are currently given, differences between 
adults and children, and the experts’ opinions on 
Table 1
Strategies for improving vaccination uptake in adult and child migrants, reported by vaccine experts in the EU/EEA, 2017 
(n = 32 countries)
Theme Examples of activity and strategy
Distribution of 
promotional material
Peer-to-peer projects 
 
Sweden: Peer-to-peer project combined with a package of communication material (film, web-based animation, 
dialogue seminars) in the Somali community based on the Tailoring Immunization Programs mapping with the WHO/
Euro tool.
Leaflets developed in different languages 
 
Germany: National level – information leaflets for each relevant vaccine in 20 languages. 
 
Bulgaria: Leaflets in the reception centres and refugee camps in Arabic, Farsi and other languages.
Poster and brochure distributed in camps regarding specific infectious disease 
 
Poland: Information sessions were carried out in Centres for Foreigners (both for employees and for asylum seekers) 
about the importance of getting vaccinated and overall information on vaccine-preventable diseases. Brochures and 
posters regarding measles are distributed in the camps (prepared in cooperation with the National Institute of Public 
Health – National Institute of Hygiene).
Education and 
awareness
Health education programmes 
 
Distribution of educational material, developed by the International Organisation for Migration, in certain countries.
Information about vaccination distributed to migrants through the (registration) centre on arrival 
 
Switzerland: Information on access to infectious diseases screening, access to care and access to vaccination is 
mandatory in centres for asylum seekers in federal registration centres and housing centres.
Outreach work
Nurses visits and advice 
 
Malta: Once migrants arrive, if they are undocumented and are in reception centres, nurses visit, advise and offer 
vaccines. Other migrants are reached through national immunisation campaigns.
Mobile outreach teams of physicians to migrant communities and reception centres 
 
Reported in Germany.
Vaccination checking in school settings 
 
Cyprus: “For children going to school, the school health services are very active in promoting the immunisations by 
checking all students for completeness of their vaccinations by asking them to present their immunisation cards. The 
parents of those students who don‘t have the necessary vaccines are contacted by phone by the school health visitor 
and they are asked to complete the missing vaccines for their child.”
National advocacy
National immunisation campaigns 
 
Reported in Malta.
Recommendations for vaccination promotion by health agencies and professionals 
 
Austria: Targeted recommendations for vaccination upon first medical check, distributed to all involved stakeholders.
Governmental walk-in centres offer free vaccination for migrants 
 
Cyprus: “People can get vaccinated or vaccinate their children in government walk-in centres completely free of 
charge. There are 63 such immunisation centres spread across Cyprus in cities and also in small communities.”
EEA: European Economic Area; EU: European Union; WHO/Euro: World Health Organization Regional Office for Europe.
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new approaches, where and what should be offered, 
approaches adopted for migrants with incomplete vac-
cination history or lack of documentation, and whether 
migrants are charged a fee for vaccinations received. 
In the open-ended questions, we asked experts to pro-
vide specific examples of innovative strategies and 
promotional activities around vaccination and immu-
nisation currently aimed at recently arrived migrants 
in their countries. The questionnaire was designed to 
take around 15 min to complete.
Approach and data analysis
Before distributing the survey, we piloted it with 
two members of the European Society of Clinical 
Microbiology and Infectious Diseases (ESCMID) Study 
Group for Infections in Travellers and Migrants (ESGITM). 
These two interviews were excluded from the analysis 
but were used to improve the questions and instruc-
tions. We amended the questionnaire based on their 
feedback. We created the ESGITM Working Group on 
Vaccination of Migrants, a group of European experts 
on infection and vaccination, and all members of the 
working group were asked to recommend a vaccination 
expert in their country. These vaccination experts had 
to be working at a national level (e.g. the Ministry of 
Health, a public health institution or equivalent) with 
expertise relating to vaccination policy and practice in 
migrants in their specific country. For six countries, for 
which a recommendation was not given by the ESGITM 
network, experts were identified through a search of 
authors of national guidelines and vaccinations docu-
ments for that specific country. These experts were 
contacted and asked whether they could complete 
the survey for their country or recommend another 
expert. We aimed to approach one national expert 
from each country. The questionnaire was sent elec-
tronically via email between March and May 2017 to 
experts in the following countries: Austria, Belgium, 
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Greece, Hungary, 
Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, 
Luxembourg, Malta, the Netherlands, Norway, Poland, 
Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, 
Switzerland and the United Kingdom. A first reminder 
was sent after 2 weeks. A second reminder was sent 1 
month later. Experts were asked to complete the elec-
tronic form and email it back to us.
Data were extracted from the completed survey forms 
by two researchers, and inputted into Microsoft Excel, 
to ensure accuracy before analysis. Descriptive analy-
ses were conducted to calculate percentages and 
proportions. Framework analysis was conducted to 
synthesise free-text responses in the open-ended 
questions [23].
Results
Survey response
All 32 experts from the 32 approached EU/EEA coun-
tries and Switzerland returned a completed question-
naire. Eight were working in Ministry of Health teams 
specifically on migration, 21 in public health teams, 
three had expertise in vaccination issues related to 
migrants – for example being part of vaccination advi-
sory groups (18 women, 14 men). Detailed information 
on the expert group and their expertise can be found 
in Supplement 2.
Vaccination guidelines: policy vs practice
Twenty-eight of 32 experts reported being aware of 
guidance at a national level on vaccination within their 
country, yet guidelines specifically focusing on migrants 
were only reported by six of 32 experts. Twenty-three 
experts reported that vaccinations were administered 
during an on-arrival health check to recently arrived 
migrants, 29 experts reported that recently arrived 
migrants were offered a health check within a month 
after arrival, and in 17 countries, this health check was 
compulsory. Countries followed the national schedule 
when seeing a migrant for the first time, with 14 of 32 
experts stating that national vaccination guidelines 
were always applied in practice in migrant patients. 
Sixteen experts reported that the guidelines were only 
partly applied in practice, whereas two reported that 
guidelines were never applied in practice. Experts 
reported that the extent to which national guidelines 
(or where available, migrant-specific guidelines), were 
implemented depended on the number of healthcare 
staff available, the number of refugees, willingness of 
healthcare staff and awareness among healthcare staff 
as to the immunisation needs of presenting migrants.
Differences in vaccination approach between 
children and adults
The vaccines offered to adults and children varied 
across countries, according to the experts consulted 
(Figure 1). DTP, polio and measles-mumps-rubella 
(MMR) vaccinations were given to migrant children in 
31 of 32 countries, with hepatitis B vaccination being 
Figure 2
Vaccine experts’ opinion on when vaccinations should be 
offered to adult and child migrants, EU/EEA, 2017 (n = 32 
countries)
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the next most commonly administered vaccine (25/32). 
In half or less than half of all reporting countries were 
child migrants offered vaccinations against tuberculo-
sis, meningococcal disease, pneumococcal disease or 
influenza. Recently arrived adult or child migrants were 
not vaccinated for hepatitis A in any country. Adult 
migrants seem to be excluded from catch-up vaccina-
tion initiatives in most countries, with experts report-
ing lower numbers of different vaccinations per person. 
Adult vaccination mainly focused on catch-up vacci-
nations for DTP, polio and MMR, but half or less than 
half of all reporting countries reported offering these 
vaccinations to adults (diphtheria: 16/32; pertussis: 
10/32; tetanus: 16/32; polio: 12/32; MMR: 13/32). Other 
vaccines were less frequently reported. Data were not 
collected in this survey on the approach taken when 
multiple doses of a vaccination are required.
Approaches adopted for migrants reporting 
incomplete vaccination history
The approach in migrants with an incomplete vac-
cination history or a lack of documentation varied by 
country. In most countries, when there was a lack of 
evidence of previous vaccination in children, or evi-
dence of incomplete vaccination, they were re-vacci-
nated according to the national schedule (n = 30). For 
adults, four countries experts reported that adults in 
this situation would not be vaccinated for anything. In 
18 countries, vaccinations that are prioritised in order 
to prevent an outbreak were administered to adults, 
whereas re-vaccination in children occurred according 
to the national vaccination schedule. One of the 32 
experts reported that they would do serological testing 
before repeat vaccinations in adults.
Financing of vaccination for migrants in the 
EU/EEA
Ten experts reported that migrants had to pay for their 
vaccination when approaching statutory services. In 
three of these 10 countries, experts stated that it was 
specifically undocumented migrants that had to pay 
for vaccinations. The need for financial contribution 
also varied by age; one expert reported that vaccina-
tion in children was free of charge and that only adults 
were charged. Another expert reported that vaccina-
tion upon arrival at the first medical check was always 
offered for free, whereas vaccinations at a later stage 
had to be paid by certain migrants.
Promotional activities and innovative strategies
Fifteen experts reported initiatives to engage migrants 
in vaccination and improve uptake, some examples of 
Table 2
Findings and points of action for governments, researchers and policy makers proposed by the vaccine expert survey, 2017 
(n = 32 EU/EEA countries)
Findings Suggested solutions
• There are a variety of approaches to vaccination of both adult and 
child migrants across the EU/EEA. 
 
• Where guidance exists, it is in most cases not migrant-specific and 
often not applied in practice. 
 
• Considerable variation in approaches exists between adults and 
children. Child migrants with uncertain vaccination status are in 
most countries re-vaccinated according to the national vaccination 
schedule. Adults often receive no catch-up vaccination, or for priority 
vaccinations only. 
 
• Adult migrants may be charged for vaccinations received at 
statutory health services in some countries, which may deter them 
from seeking vaccination and other preventative healthcare. 
 
• There is considerable variation among experts as to which vaccines 
should be offered to recently arrived migrants, particularly adults, 
and experts call for clear evidence-based guidance on this issue. 
 
• It is unclear where vaccination should be offered to improve uptake. 
Most experts agreed that focus should be soon after arrival, at the 
holding level (reception centres, refugee camps or detention centres) 
and be better promoted.
• Develop EU-level guidelines for vaccination of recently arrived adult 
and child migrants, with clarification given on which vaccines should 
be offered. 
 
• Multiple approaches are needed to engage and promote vaccination 
uptake in migrants, across multiple locations. 
 
• Vaccination needs to be free of charge for all migrant groups, 
including undocumented migrants. 
 
• Better explore models of best practice from across the EU/EEA to 
assess innovative strategies to improve vaccine delivery to adult and 
child migrants.  
 
• High quality studies are needed assessing vaccination 
implementation and cost-effectiveness in migrant populations. 
 
• Explore options for improving data collection and surveillance on 
vaccination coverage and burden of vaccine-preventable diseases in 
migrant populations across Europe. 
 
• Explore options for improving data capture to avoid duplication 
of efforts and unnecessary repeat vaccination along the migration 
trajectory (for example by non-governmental organisations in transit 
camps and also at statutory health services) after arrival to Europe 
(e.g. use of mobile phones, electronic vaccination cards and personal 
health records). 
 
• Explore the role of migrants (including underimmunised internal 
EU migrants and of adolescent and adult migrants), in outbreaks of 
vaccine-preventable diseases in the EU through robust research, and 
identify strategies to facilitate improved vaccine coverage in these 
groups.
EU/EEA: European Union/European Economic Area.
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which are outlined in  Table 1. Promotional activities 
and innovative strategies were organised at different 
levels of the healthcare system;  Table 1  shows the 
diversity of the strategies across Europe. However, we 
have no data on how effective or evidence-based these 
different approaches are, and where leaflets had been 
translated to make them more accessible they were 
not always translated into sufficient dominant migrant 
languages. In addition, it needs to be acknowledged 
that a lack of literacy in some migrant groups can be a 
major barrier to healthcare and vaccination.
Recommendations to improve vaccination 
strategies in migrants
Most experts agreed that EU-level guidelines on the 
vaccination of migrants are needed (n = 26). Nineteen 
experts believed that vaccination should be better pro-
moted. Other experts emphasised the need for detec-
tion of vaccine-preventable diseases (n = 6) and called 
for a new surveillance system to record information 
on vaccination status in asylum seekers. In addition, 
costs of vaccinations should be covered by national 
organisations (n = 4).
To improve uptake of vaccination, experts highlighted 
that multiple opportunities for catch-up vaccination 
should be offered to adult and child migrants after 
arrival to the EU/EEA. Vaccination should be offered 
primarily at the point of entry or at a holding level (i.e. 
in reception centres, migrant camps and detention cen-
tres) (Figure 2).
Discussion
Vaccination policies across Europe in relation to both 
adult and child migrants vary widely. Experts reported 
that national vaccination guidelines are used and these 
guidelines contain information on how to approach 
migrant patients with missed vaccinations and to 
offer catch-up vaccinations. However, these guidelines 
are often not migrant-specific and are frequently not 
applied in practice, particularly in relation to catch-up 
vaccination in adult migrants. Considerable variations 
in approaches exist between adults and children; chil-
dren mostly enter the national vaccination schedule, 
whereas adults receive no catch-up vaccination or 
priority vaccinations only. The experts from 10 of 32 
countries reported that migrants have to pay for vac-
cination. Almost half of the experts reported initiatives 
to promote vaccination among migrant groups, but evi-
dence for a sound theoretical basis is lacking. Experts 
stated that better promotion for vaccination is needed 
and implementation should be strengthened.
Priority is given to child vaccination in most EU/EEA 
countries. Vaccination guidelines include recom-
mendations for children with incompletely vaccina-
tion. However, recommendations on the catch-up 
schedule to follow in case of missed vaccinations for 
both adults and children may vary by vaccine and by 
country. A study in 2011 that assessed immunisation 
policies across all EU/EEA countries – although not 
migrant-specific – found that all 27 countries recom-
mended MMR and polio vaccinations for children, and 
only 11 of the 27 countries included MMR and polio 
vaccine for adults [24]. This concurs with our results 
pertaining to migrants, where vaccination for MMR and 
polio in migrant children is reported in all included 
countries and vaccination of adults only in half of the 
EU/EEA countries; this is despite the fact that some 
migrants originate from countries where health sys-
tems may have broken down resulting in immunisa-
tions being missed [25,26]. The Canadian guidelines, 
based on a systematic review of available evidence, 
recommend that MMR, DTP, polio, varicella and hepa-
titis B vaccines should be given to children and adult 
migrants [27], whereas our survey highlights that in 
more than half of EU/EEA countries these would not 
routinely be offered to adults and thus this represents 
an area requiring policy development [10]. Measles 
vaccine should be considered in both children and 
adult migrants in light of the fact that there have been 
outbreaks of measles in the EU that have been linked 
to migrant populations specifically, and there is a drive 
to eliminate measles in the European region [12,13]. 
Experts reported that hepatitis A was not routinely 
given, despite outbreaks of hepatitis being reported in 
migrant camps in Europe [11], yet the benefits of vac-
cinating migrants for hepatitis A may well be context-
specific and something that needs to be considered a 
priority in camp and transit settings and/or focused on 
at-risk groups. EU/EEA countries may need to be mind-
ful of additional vaccines such as influenza, hepatitis 
B and varicella vaccines that may need to be offered to 
migrants depending on living conditions, season and 
the epidemiological situation.
Barriers that have been shown to hinder adult vac-
cination uptake in general include lack of coordina-
tion, inability to pay and a lack of recommendation 
by healthcare providers [28,29], which echoes our 
findings pertaining to recently arrived migrants. Most 
migrants and refugees will not routinely be given a 
portable health record on arrival to the EU/EEA, so if 
they do get vaccinated in a transit or arrival country, 
this may result in duplication and/or confusion as to 
which vaccinations to give on arrival in the final des-
tination country. The role of portable health records to 
ensure that a record is made of the vaccinations given 
at various points in the migration trajectory, with the 
aim of preventing duplication of vaccination, was not 
something we explored in this survey, but is an area 
that needs to be better considered. The International 
Organization for Migration (IOM), co-funded by the EU 
Third Health Programme, is currently piloting general 
health and vaccination assessments and exploring the 
role of electronic personal health records (e-PHR) in 
certain migrants arriving to Croatia, Greece, Italy and 
Slovenia as a tool for integration of refugees into EU 
health systems (https://greece.iom.int/en/re-health). 
To implement guidelines more effectively, the experts 
we approached recommended strong promotional 
campaigns and a harmonised vaccination schedule, 
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which has been reported by others [5,30]. Educational 
activities to promote vaccination uptake by migrants 
were diverse, but the impact of these activities has 
not been well researched to date. These educational 
activities may benefit from further European collabo-
ration, which has the potential to facilitate exchange 
of material in the appropriate languages and exchange 
of methods with measurable effects on vaccination 
uptake. The experts we approached called for EU-level 
guidelines to inform optimal approaches, which would 
support the goals of the European Vaccine Action Plan. 
Differences in countries’ healthcare systems and vac-
cine delivery structures need to be addressed [31]. 
Early access to primary care providers may be helpful 
in coordinating vaccine campaigns; yet it is unclear to 
what extent different countries have charging systems 
in primary care specifically for vaccination and this is 
not something we asked about in our survey. Another 
major challenge in terms of implementation is that 
countries across Europe face vastly different migrant 
situations – for example, transit countries such as 
Greece and Italy have large numbers of refugees arriv-
ing who may be temporary, which has implications for 
guideline development. The financing of vaccination 
programmes also needs to be considered in the con-
text of migration. To improve uptake of vaccination in 
migrants, costs for key vaccinations should ideally be 
free of charge for migrants who are unable to pay, with 
European governments being mindful of their com-
mitments to ensure equitable access to vaccines to 
meet target 3.8 of the Sustainable Development Goal 
on health to provide “access to safe, effective, qual-
ity, and affordable essential medicines and vaccines 
for all” [32]. Routine checks of vaccination status in 
medical files may facilitate the identification of miss-
ing vaccinations that can be addressed if migrants visit 
statutory healthcare providers after arrival.
Clinicians and policymakers should also be mindful 
that both EU migrants – moving from one country in 
Europe to another – and non-EU migrants that were the 
focus of our survey, may be underimmunised and at 
increased risk for vaccine-preventable diseases; highly 
mobile EU migrants moving from eastern Europe to 
western Europe are a focus of the recent large multi-
country measles epidemic in Europe [32]. In addition, 
more research is needed to explore catch-up vaccina-
tion in adolescent migrants who – alongside the adults 
identified in our survey – may also be an underim-
munised group who are excluded from initiatives to 
assess immunisation status and offer appropriate 
catch-up vaccination, with national vaccination initia-
tives largely focused around children under 5 years of 
age [7,32]. In a cohort of asylum seekers in Denmark, 
401 (48%) of 842 adolescents (aged 10–17 years) 
were reported as unimmunised or status unknown [7]. 
Further, it is important to note that migrants are one of 
several potentially underimmunised groups in the EU/
EEA region. Data are lacking to what extent underim-
munised groups contribute to outbreaks of vaccine-
preventable diseases in the region, and improving 
data collection around migrant status and vaccine-
preventable diseases, is an important next step. Table 
2 summarises key points of action.
A limitation of our study is that we asked one expert 
at national level for each specific EU/EEA country and 
Switzerland, which may mean we have missed docu-
menting regional differences. In addition, although 
we clearly defined at the top of the questionnaire the 
types of recently arrived migrants that we were aim-
ing to capture data on, an expert’s own definition of 
a migrant may have meant that some answers did not 
fully represent the target group. Our experts were all 
working in the Ministry of Health or in public health, 
but we are aware that there are other entities providing 
vaccination, e.g. non-governmental organisations. We 
cannot conclude from our findings that the policies we 
have documented are applied in practice country-wide. 
A strength of our study is that we included all 32 EU/
EEA countries and Switzerland, with a previous study 
exploring similar issues in six countries [33].
Conclusion
Our data show that there is a need for migrant-specific 
guidelines on vaccination approaches for both chil-
dren and adults in the EU/EEA. To improve uptake, 
guidelines on vaccination in migrant populations 
should include specific information on implementa-
tion. Further European collaboration has the potential 
to strengthen initiatives to improve vaccination uptake 
in underimmunised migrant groups.
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